Cholangiocarcinoma

Cause of Cholangiocarcinoma

The etiology of cholangiocarcinoma is still unclear. May be related to the following factors:

•  Bile duct stones: One-third of bile duct cancer patients have bile duct stones and for these patients 5%-10% develop into bile duct cancer because stones stimulate the bile duct for long periods causing repeated inflammation of epithelial cells which then become malignant into bile duct cancer cells.

• Clonorchis sinensis (liver fluke): The consumption of raw fish containing liver flukes in Southeast Asia leads to biliary tract infection alongside bile stasis and bile duct hyperplasia and this condition produces bile duct fibrosis which ultimately causes bile duct cancer.

• Cystic dilation of the bile duct: Cancer development remains rare but possible in patients who experience cystic dilation of the bile duct. The abnormal proximity between the biliary pancreatic junction and Vater's ampulla enables pancreatic juice reflux which stimulates the bile duct repeatedly causing chronic cholangitis which develops into cholangiocarcinoma.

Medical Examinations for Cholangiocarcinoma

• Laboratory Examination

The levels of blood total bilirubin, direct bilirubin, alkaline phosphatase, and gamma glutamyltransferase show significant elevation. Doctors can identify this condition by noticing the mild abnormalities in transaminase levels alongside alterations in bilirubin which help differentiate from viral hepatitis. Abnormal liver function in patients can lead to extended prothrombin time measurements. Elevated levels of CA19-9 and CEA can be present in certain patients.

• Ultrasonic Imaging Examination

B-ultrasound examination is simple, fast, accurate, and cost-effective, and can detect: Ultrasonic imaging examination detects duct dilation throughout the liver and outside the liver and shows the exact location of biliary blockages while determining the kind of obstruction. In cases of obstructive jaundice the preferred diagnostic tool is an ultrasound examination. Endoscopic ultrasound avoids interference from intestinal gas while its high frequency ultrasound probe displays extrahepatic bile duct tumors with greater clarity. The technique accurately assesses the invasion depth in middle and lower bile duct tumors as well as hilar bile duct cancers and identifies regional lymph node metastasis. By using ultrasound guidance medical professionals can perform cholangiography directly and extract bile through a puncture technique to assess CA19-9 and CEA levels while also conducting bile cytology examinations. Under ultrasound direction doctors can puncture pathological tissue to perform histological examination.

• Percutaneous Transhepatic Cholangiography (PTC)

PTC provides clear visualization of the morphology and distribution of bile duct obstructions in both intrahepatic and extrahepatic regions. This procedure requires invasive intervention and patients often face severe complications such as postoperative bleeding and bile leakage.

• CT Scan

CT imaging provides precise information about the location and size of bile duct dilation and blockages and accurately identifies lesion characteristics. Three dimensional spiral CT cholangiography (SCTC) shows potential to replace PTC and ERCP examinations.

• Magnetic Resonance Cholangiopancreatography (MRCP)

MRCP examination functions as a non-invasive technique for biliary imaging. The imaging examination method known as MRCP stands as the preferred choice for inspecting hilar cholangiocarcinoma because it produces comprehensive visualizations of intrahepatic bile ducts along with tumor obstruction locations and extents while revealing liver parenchymal invasion or metastasis presence.

• Nuclide Imaging Scanning

Dynamic images of the biliary tract are captured through intravenous injection of 99mTc EHIDA followed by continuous gamma camera imaging.

• Selective Hepatic Angiography and Portal Vein Angiography

We aim to analyze how portal vein and hepatic artery interact with tumors to evaluate tumor resectability before surgery. Digital subtraction angiography (DSA) shows how hepatic portal blood flow interacts with tumors which helps in planning radical surgery for cholangiocarcinoma.

Treatment Strategies

Patient management strategies demand evaluation of tumor stage and location in addition to the patient's fitness level.

The battle against cholangiocarcinoma will see major advancements only when early detection methods improve alongside personalized medical treatments and innovative therapies. Surviving cholangiocarcinoma requires a comprehensive support system. Patients need to utilize available resources, maintain communication with their care team, and prioritize quality of life to effectively manage this complex disease.